Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > is it too much to ask for

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Feb 16, 2023 5:04pm

118 Views

Post# 35290856

RE:RE:is it too much to ask for

I see it similarly. All we can do is assume they will submit to the FDA in Q1 as promised. Do we know that they have submitted yet? No, not at all. It's possible they have, and it's possible they haven't. I'm not going to start getting concerned again until mid to late April. The #s can change easily for the better, or worse, due to a currently small sample size. Can't wait to hear about the latest data updates, whenever that is.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario